×

Human anti-IL-23 antibodies, compositions, methods and uses

  • US 7,935,344 B2
  • Filed: 12/28/2006
  • Issued: 05/03/2011
  • Est. Priority Date: 12/29/2005
  • Status: Active Grant
First Claim
Patent Images

1. An isolated IL-23p19 antibody, comprising a light chain variable region and a heavy chain variable region, said light chain variable region comprising:

  • a complementarity determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO;

    50;

    a CDRL2 amino acid sequence of SEQ ID NO;

    56; and

    a CDRL3 amino acid sequence of SEQ ID NO;

    73,said heavy chain variable region comprising;

    a complementarity determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO;

    5;

    a CDRH2 amino acid sequence of SEQ ID NO;

    20; and

    a CDRH3 amino acid sequence of SEQ ID NO;

    44.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×